Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00815
|
|||||
| Drug Name |
Sertindole
|
|||||
| Synonyms |
1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indole-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone; 1-(2-(4-(5-Chloro-1-(p-fluorophenyl)indol-3-yl)piperidino)ethyl)-2-imidazolidinone; 1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone; 1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl}ethyl)imidazolidin-2-one; 1-[2-[4-[5-Chloro-1-(p-fluorophenyl)indol-3-yl]piperidino]ethyl]-2-imidazolidinone; 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one; 1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one; Lu 23-174; Lu-23-174; S-1991; SerLect; SerLect (TN); Serdolect; Serdolect (TN); Serlect (TN); Sertindol; Sertindol [INN-Spanish]; Sertindole (USAN/INN); Sertindole [USAN:INN]; Sertindole hydrochloride; Sertindolum; Sertindolum [INN-Latin]
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antipsychotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C24H26ClFN4O
|
|||||
| Canonical SMILES |
C1CN(CCC1C2=CN(C3=C2C=C(C=C3)Cl)C4=CC=C(C=C4)F)CCN5CCNC5=O
|
|||||
| InChI |
InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)
|
|||||
| InChIKey |
GZKLJWGUPQBVJQ-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 106516-24-9
|
|||||
| Pharmaceutical Properties | Molecular Weight | 440.9 | Topological Polar Surface Area | 40.5 | ||
| Heavy Atom Count | 31 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| XLogP |
4.1
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
ChEBI:9122
|
|||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.